About Us

Who We Are?

Founded in 1994, Rusan Pharma is a fully integrated global pharmaceutical company specializing in the treatment of addiction and pain management. Rusan’s manufacturing company for active pharmaceutical ingredients (API) and finished pharmaceutical formulations, live up to some of the highest standards of good manufacturing practices (GMP) and are approved by Health Canada.

Rusan Pharma Canada Inc. (RPCI) is the Canadian subsidiary of Rusan Pharma Ltd. (India), a generic pharmaceutical company located in Montreal, Québec. With a strong product development pipeline and strategic partnerships, we pride ourselves in delivering high quality and affordable generic pharmaceutical medicines to the Canadian market. Through product differentiation, best-in-class supply and excellent service, we strive to help families across Canada live longer, healthier and happier lives.

Our Mission

Rusan firmly believes that access to quality healthcare is a right, not a privilege. We will endeavour to ensure the availability of world class, innovative, quality medicines at affordable prices, across the globe and are committed to work towards a healthier & happier world.

Our Vision

To bring forward innovative, highly quality novel and generic medications at affordable prices for our consumers.

API Active Pharmaceutical Ingredient (API)

Our Active Pharmaceutical Ingredient (API) manufacturing facility in India, is approved by Health Canada and the European Directorate for the Quality of Medicines & HealthCare (EDQM). Rusan has CEP for most of its niche APIs.

As part of our B-2-B services, Rusan can also provide the best quality APIs to the Canadian pharmaceutical companies at the most competitive rates.

API Enquiry
API GRADE CAS No. STATUS
Methadone hydrochloride Ph.Eur./USP 1095‐90‐5 CEP available
Buprenorphine Ph.Eur. 52485‐79‐7 CEP available
Buprenorphine hydrochloride Ph.Eur./USP 53152‐21‐9 CEP available
Fentanyl Ph.Eur./USP 437‐38‐7 CEP available
Fentanyl Citrate Ph.Eur./USP 990‐73‐8 CEP available
Bisoprolol Fumarate Ph.Eur./USP 104344-23-2 CEP available
Naltrexone hydrochloride (dihydrate) Ph.Eur./USP 850808-02-5 CEP available
Nalmefene hydrochloride (monohydrate) Non-pharmacopeial/ CHP 1228646-72-7 DMF in CTD available
Nalbuphine hydrochloride (dihydrate) Non-pharmacopeial 59052-16-3 DMF in CTD available
Eflornithine hydrochloride monohydrate Non-pharmacopeial 96020‐91‐6 Approved by Health Canada, Swissmedic & EMEA / DMF Submitted to USFDA
Apomorphine hydrochloride hemihydrate Ph.Eur./USP 41372‐20‐7 DMF in CTD available/Submitted for CEP
Naloxone hydrochloride dihydrate Ph.Eur./USP 51481‐60‐8 DMF in CTD available/Submitted for CEP
API Enquiry

Pain Management

Improving the quality of life for those with chronic pain through our therapeutic segment.

Product Description Strength Fill Size Format Pack Size Rusan Code DIN Product Monograph
RPC - Nalbuphine Injection 10 mg/ml 1 ml Ampoule 10 - - -
RPC - Nalbuphine Injection 20 mg/ml 1 ml Ampoule 5 - - -
RPC - Fentanyl Injection 50 mcg/ml 2 ml Ampoule 10 - - -
RPC - Fentanyl Injection 50 mg/ml 10 ml Ampoule 5 - - -
Product Enquiry

Drug Dependence

Helping you regain control of your life by making the de-addiction process as effortless as possible.

Product Description Strength Fill Size Format Pack Size Rusan Code DIN Product Monograph
RPC – Methadone Hydrochloride Oral Concentrate
(Cherry Flavoured  Solution)		 10 mg/ml 1000 ml Syrup 1 HDPE Bottle - - -
RPC - Methadone Hydrochloride Oral Concentrate
(Dye-Free, Sugar-Free, Unflavored Solution)		 10 mg/ml 1000 ml Syrup 1 HDPE Bottle - - -
RPC - Buprenorphine Sublingual Tablets 2 mg N/A Tablet Strip of 10 Tablets - - -
RPC - Buprenorphine Sublingual Tablets 8 mg N/A Tablet Strip of 7 Tablets - - -
Product Enquiry

Alcohol Dependence

Helping you regain control of your life by making the de-addiction process as effortless as possible.

Product Description Strength Format Pack Size Rusan Code DIN Product Monograph
RPC – Naltrexone Tablet N/A Tablet Strip of 30 Tablets - - -
Strip of 30 Tablets - - -
Product Enquiry

Tobacco Dependence

Helping you regain control of your life by making the de-addiction process as effortless as possible.

Generic Name Strength Formulation Remarks
Nicotine Transdermal Patch 21 mg / 24 hrs Patch Developed
Nicotine Transdermal Patch 14 mg / 24 hrs Patch Developed
Nicotine Transdermal Patch 7 mg / 24 hrs Patch Developed
Click Here To Know More

Over The Counter (OTC)

Generic Name Strength Formulation Remarks
Psyllium Husk Sachets 3.5 g Sachets Registered
Click Here To Know More

Other Products

Coming Soon...

Approved By

Dehradun, Uttarakhand, India
Dosages Form Annual Production Capacity

Tablets

4300 Million

Capsules

21 Million

Liquid Orals

9.36 Million Bottles (100 ml)

Ampoules

90 Million (1 ml)

Vials

40 Million (1 ml)
Contract Manufacturing Enquiry

Approved By

Transdermal Patch Facility

Kandala Unit II, Gujarat, India

Dosages Form

Annual Production Capacity

Transdermal Patches

10.8 Million
Contract Manufacturing Enquiry

Navin Saxena Research & Technology Pvt. Ltd. (NSRT)

NSRT, an affiliate of Rusan pharma, is a state-of-the-art research centre in the Kandla Special Economic Zone (KASEZ; Gujarat, India). With a rich experience of more than 25 years, in pharmaceutical development & manufacturing, NSRT is capable of undertaking cutting-edge research. Our research team comprises of versatile and specialized pool of scientists in the field of computer aided drug design, development and manufacturing of API and novel drug delivery systems.


NSRT is capable of undertaking R&D projects for custom API synthesis and development of finished formulations and in partnership with Rusan Pharma, undertake commercial production for the Canadian market.

Visit Website

Quantys Clinical Pvt Ltd. (QCPL)

QCPL is a 104 bed clinical research organization (CRO) with five independent clinics with collapsible partitions, enabling QCPL to conduct large, mixed population and multiple studies at the same time. QCPL's  trained & dedicated staff brings in considerable experience in conducting Pharmacokinetic (PK) and Clinical trial studies for various finished formulations.


QCPL's partnerships with Investigators, Institution, NGO’s, Hospitals and Clinics, enable it to recruit not just healthy volunteers but ‘Special Volunteer Groups’ to cater to the specific study requirements.


QCPL can provide PK and clinical trial study services to Canadian Pharmaceutical companies looking to conduct such studies.

Visit Website

Product Pipeline

Innovation is the cornerstone of Rusan’s vision & mission. Our rich development portfolio focuses in the area of addiction treatment, pain management and Parkinson’s. To partner with Rusan on some of our novel & generic transdermal patch products connect with us: formulation.enquiry@rusanpharma.com

Indication Program / Regulatory Pathway Preclinical Phase-I Phase-II Phase-III Approval
Alcohol Use Disorder Antagonist Prodrug Sustained Release Injection (Monthly)
Phase-II
Opioid Use Disorder Partial Agonist Sustained Release Injection (Weekly & Monthly)
Phase-II
Pain Management Partial Agonist Prodrug Sustained Release Injection (Weekly)
Phase-II
Pain Management Partial Agonist Nasal Spray
Phase-I
Parkinson’s Dopamine Agonist Nasal Spray
Phase-I
Development Enquiry

Generic Transdermal Patches & Oral Film

For exploring in-licensing opportunities for our transdermal patch portfolio for the Canadian market, please Email us on: formulation.enquiry@rusanpharma.com

For Transdermal Patch & Oral Film Portfolio Licensing
Generic Name Remarks
Nicotine Patch Under Development
Nicotine Oral Flim Under Development
Buprenorphine + Naloxone Sublingual Flim Under Development
Buprenorphine Patch Under Development
Fentanyl Patcht Under Development
Rivastigmine Patch Under Development
Rotigitine Patch Under Development
Lidocaine Patch Under Development

Career

"Great Products are the brainchild and hard work of great people. Join a young, dynamic, fast-growing and inclusive company where you have the opportunity to aim high, fulfil your potential, and achieve great things!"

Submit Resume Visit Career Page

Adr Reporting

For Medical Information Questions, Adverse Effects, Product Quality Complaints please fill this form.